Moderna (MRNA) Change in Inventory (2020 - 2026)

Moderna (MRNA) has 7 years of Change in Inventory data on file, last reported at -$6.0 million in Q1 2026.

• Change in Inventory for Q1 2026 came in at -$6.0 million, down 175.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.0 million (up 111.9% YoY), and the FY2025 annual result was $34.0 million, up 140.96% from the prior year.
• Change in Inventory advanced to -$6.0 million in Q1 2026 per MRNA's latest filing, from -$179.0 million in the prior quarter.
• Over five years, Change in Inventory peaked at $501.0 million in Q1 2022 and troughed at -$1.1 billion in Q4 2022.
• A 5-year average of -$76.1 million and a median of -$6.0 million in 2026 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2022 and 2025: Change in Inventory sank 336.97% in 2022, then soared 727.27% in 2025.
• A 5-year view of Change in Inventory shows it stood at -$1.1 billion in 2022, then jumped by 74.73% to -$285.0 million in 2023, then declined by 2.11% to -$291.0 million in 2024, then jumped by 38.49% to -$179.0 million in 2025, then soared by 96.65% to -$6.0 million in 2026.
• Business Quant data shows MRNA's Change in Inventory at -$6.0 million in Q1 2026, -$179.0 million in Q4 2025, and $91.0 million in Q3 2025.